At 1pm on the 26th March 2021, the COVID-19 Genomics UK (COG-UK) consortium presented its second ‘Showcase Event’. Watch the recording of the event here. The agenda is below.
0:00 - 2:47 Opening remarks, Professor Sharon Peacock, Executive Director and Chair, COG-UK
Session 1. SARS-CoV-2: new insights into molecular tests and massive sequencing, Chair: Dr Catherine Ludden, University of Cambridge
2:48 – 21:18 Lessons from large-scale SARS-CoV-2 sequencing, Dr Cordelia Langford, Wellcome Sanger Institute
21:19 – 28:44 SARS-CoV-2 mutations and diagnostic test accuracy – PART 1, Dr Kate Templeton, University of Edinburgh
28:45 – 44:19 Non-sequence based molecular methods to detect SARS-CoV-2 variants, Dr Leigh Jackson, Public Health England
44:20 – 50:50 SARS-CoV-2 mutations and diagnostic test accuracy – PART 2, Dr Kate Templeton, University of Edinburgh
Session 2. SARS-CoV-2 variants: distribution, detection and prioritization, Chair: David Robertson, University of Glasgow
53:45 – 1:08:22 Overview of the global epidemiology of SARS-CoV-2 lineages of global concern, Áine O'Toole, University of Edinburgh
1:08:23 – 1:23:56 SARS-CoV-2 mutation and variant surveillance at the Wellcome Sanger Institute, Matt Sinnott, Wellcome Sanger Institute
1:23:57 – 1:39:57 Prioritizing SARS-CoV-2 mutations and variants, Dr Alessandro Carabelli, University of Cambridge
Session 3. SARS-CoV-2 variants: patients and prevention, Chair: Dr Sally Corden, Public Health Wales
1:42:09 – 1:56:37 SARS-CoV-2 variants – what we can learn from the HOCI study, Professor Judy Breuer, University College London
1:56:38 – 2:16:52 SARS-CoV-2 Variants, Vaccines and Immune Escape, Professor Wendy Barclay, Imperial College London
2:16:53 – 2:30:54 B.1.1.7 causes more severe disease. True or False? Dr Nick Davies, London School of Hygiene & Tropical Medicine
2:30:55 Thanks and close, Professor Sharon Peacock, Executive Director and Chair, COG-UK
